Home Page / News / Saadia Pharmaceuticals Team Publishes Long-Term Study on Lybalvi Ⓡ (Alkermes Pharmaceuticals) for Sustained Weight Loss in Schizophrenia and Bipolar I Disorder
Saadia Pharmaceuticals Team Publishes Long-Term Study on Lybalvi Ⓡ (Alkermes Pharmaceuticals) for Sustained Weight Loss in Schizophrenia and Bipolar I Disorder
